New Thermo Scientific Cascadion SM Clinical Analyzer with 25-Hydroxy Vitamin D Assay Available in the U.S.

New Thermo Scientific Cascadion SM Clinical Analyzer with 25-Hydroxy Vitamin D Assay Available in the U.S. VANTAA, Finland, March 16, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that its Thermo Scientific Cascadion SM Clinical Analyzer is now commercially available in the U.S. with the Cascadion SM 25-Hydroxy Vitamin D... Read more

FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19

FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19 WALTHAM, Mass., March 13, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its diagnostic test that... Read more

Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer

Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer CARLSBAD, Calif., March 12, 2020 /PRNewswire/ — Thermo Fisher Scientific announced today it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to co-develop a companion diagnostic (CDx) in oncology. The CDx will... Read more

Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development

Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development WALTHAM, Mass., March 10, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Paul G. Parker will join the company, effective April 15, 2020, as senior vice president, strategy and corporate development, which also... Read more

Thermo Fisher Scientific Launches New LC-MS/MS Clinical Analyzer with 25-Hydroxy Vitamin D Assay in the U.S.

Media Contact Information Julia Nisbet-FahySenior Manager – Global MarketingThermo Fisher Scientific+44 (0) 7342 080967julia.nisbet-fahy@thermofisher.com Jaime GrigorescuMarketing Manager – Global MarketingThermo Fisher Scientific+1 (773) 431 0390jaime.grigorescu@thermofisher.com New Thermo Scientific Cascadion SM Clinical Analyzer with 25-Hydroxy Vitamin D Assay Available in the U.S. The Thermo Scientific Cascadion SM Clinical Analyzer.  To download this image, click here. VANTAA, Finland – (March 9,... Read more

Bruker Introduces Novel NMR Technologies and Lab Productivity Software at ENC 2020

New Magnetic Resonance Technologies and Applications Open New Frontiers for Biological, Chemical and Materials Research BALTIMORE, Maryland – March 9, 2020 – Continuing its mission to bring enabling magnetic resonance capabilities to customers, Bruker highlights new life-science research tools and innovative lab software solutions at the 61st Experimental Nuclear Magnetic Resonance Conference (ENC). The new technologies... Read more

New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance

New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance Thermo Scientific MIC-6 Multi-Instrument Calibrator Designed to Streamline U.S. EPA LDAR Compliance MINNEAPOLIS, March 9, 2020 /PRNewswire/ — For refineries and petrochemical plants, a new multi-instrument calibrator is designed to save time and improve accuracy of daily calibrations and... Read more

New Functional Structural Biology Capabilities Enabled by Bruker GHz-Class NMR Technology

First 1.2 GHz NMR System Delivered to CERM at the University of Florence, Italy BALTIMORE–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference 2020 (ENC), Bruker Corporation (Nasdaq: BRKR) announces the recent delivery of the world’s first Avance™ NEO1.2 GHz NMR system to the CERM at the University of Florence, Italy, and the first installation... Read more

PerkinElmer First Quarter 2020 Financial Performance Update

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it expects first quarter 2020 revenue and earnings per share, both on a GAAP and non-GAAP basis, to be below the Company’s previously communicated guidance. Prahlad Singh, president and chief executive officer of PerkinElmer, stated,... Read more

Bruker Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of Bruker’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Form 10-K”), Bruker is... Read more